Evidence map›Paper›PMID 38726898›Full record

ArticleJournal of the American Heart Association2024

TPT-004, a Next-Generation Inhibitor of Tryptophan Hydroxylase, Ameliorates Pulmonary Arterial Hypertension in Rats.

Radoslaw Wesolowski, Dirk Pleimes, Edgar Specker, Michael Bader

Abstract readLetter
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Radoslaw WesolowskiMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC) Berlin Germany.ORCID 0009-0002-7228-1051
Dirk PleimesTrypto Therapeutics GmbH Berlin Germany.ORCID 0000-0002-0876-9418
Edgar SpeckerTrypto Therapeutics GmbH Berlin Germany.ORCID 0000-0002-9471-9520
Michael BaderMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC) Berlin Germany.ORCID 0000-0003-4780-4164

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Tryptophan HydroxylaseAnimalsAntihypertensive AgentsDisease Models, AnimalEnzyme InhibitorsHypertension, PulmonaryMalePulmonary Arterial HypertensionPulmonary ArteryRatsRats, Sprague-DawleyAntihypertensive AgentsEnzyme InhibitorsTryptophan Hydroxylasepulmonary arterial hypertensionserotoninTPH inhibitortryptophan hydroxylase

Identifiers

PMID38726898
PMCPMC11179815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.